On May 7, the U.S. Food and Drug Administration (FDA) permitted marketing of Hemospray, a new device used to help control certain types of bleeding in the GI tract. Read more via FDA.gov.
Δ
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Notifications
